Understanding the Body and Disease Process

1913

After a number of years in medical practice, Dr. Oswald Avery pursued medical research

Learn more

1923

Dr. Pierre Masson's early research led to the publication of his classic text "Les Tumeurs Humaines"

Learn more

1940s

At McGill, Dr. Charles Leblond found the opportunity to attempt his autoradiography experiment again, this time using an isotope with a longer half-life

Learn more

1944

The Journal of Experimental Medicine published the breakthrough discovery of Avery, MacLeod and McCarty

Learn more

1948

Drs. Barr and Bertram made a ground-breaking discovery later referred to as the Barr body

Learn more

1953

Along with his student Yves Clermont, Dr. Charles Leblond discovered the first mammalian stem cells

Learn more

1953

Watson and Crick discover the structure of DNA

Learn more

1955

With Dr. K.L. Moore, Dr. Barr developed the buccal smear test, a non-invasive method of gathering human cells from the lining of the mouth for genetic testing

Learn more

1956

Louis Siminovitch joins the Ontario Cancer Institute

Learn more

1960's

For the next 15 years, Drs. McCulloch and Till pursued stem-cell research

Learn more

1961

Till and McCulloch published their original paper describing stem cells in Radiation Research

Learn more

1963

Ernest McCulloch and James Till published their findings in "Nature"

Learn more

1963

Lou Siminovitch provides input to the fledgling stem cell research group with Drs. Till and McCulloch

Learn more

1969

Dr. MacLennan began his studies of the SR—a calcium storage and release compartment inside muscle cells

Learn more

1970

Dr. Lou Siminovitch appointed Geneticist-in-Chief at The Hospital for Sick Children

Learn more

1970s

Dr. Michael Smith focused his research on the human genome and on developing methods to sequence DNA molecules called oligonucleotides

Learn more

1971

Dr. Worton returned to Canada and joined the Department of Genetics at The Hospital for Sick Children (SickKids) in Toronto as Director of the Cytogenetics Laboratory

Learn more

1979

Dr. John Bienenstock was one of the first to identify the T cell-dependent mucosal mast cell as a major effector cell of parasite gut immunity

Learn more

1979

Dr. Michael Hayden established the 1st Huntington’s Disease Clinic in South Africa

Learn more

1980

Dr. Joseph Martin developed an NIH-sponsored Huntington’s Disease Research Center at Massachusetts General Hospital that brought together scientists from Harvard, MIT and Boston University

Learn more

1981

Dr. Eaves co-founded the Terry Fox Laboratory at the BC Cancer Agency

Learn more

1982

Dr. Worton devised a five year research plan to identify the gene responsible for Duchenne Muscular Dystrophy using DNA from Dr. Verellen's patient.

Learn more

1984

Known as the “holy grail” of immunology, Dr. Mak discovered the structure of the T-Cell captor for antigens

Learn more

1985

Dr. Lap-Chee Tsui completed a four-year tour-de-force to map the cystic fibrosis gene to a position on human chromosome 7

Learn more

1985

Dr. Worton began a ten-year term as Geneticist-in-Chief at the Hospital for Sick Children. That same year he, along with colleague Dr. Peter Ray, identified a portion of the X chromosome containing…

Learn more

1986

Dr. Pawson developed the concept of signaling proteins and identified the Src homology 2 (SH2) domain as the prototypic protein-interaction module

Learn more

1986

To facilitate increased scientific collaboration, Dr. Hayden established the Canadian Collaborative Network on Predictive Testing for Huntington's Disease

Learn more

1989

Along with Dr. Michael Hayden, Dr. Worton developed the successful proposal to create the Canadian Genetic Diseases Network (a Network of Centres of Excellence) and served as its Associate Director…

Learn more

1989

Dr. John Dick developed the first xenograft assay (the implantation of human tumour cells into immunocompromised mice) for human leukemia cells

Learn more

1989

Dr. Worton joined a small group of geneticists in Geneva to create HUGO, the international Human Genome Organisation.

Learn more

1989

The discovery of the CFTR gene defective in cystic fibrosis was published in three foundational papers in Science magazine and received worldwide acclaim as the first disease gene to be identified…

Learn more

1990

The Human Genome Project began

Learn more

1992

Dr. David MacLennan published his research on the genetic basis of malignant hyperthermia in swine in the journal "Trends in Pharmacological Sciences"

Learn more

1992

Dr. Worton was appointed Director of the Canadian Genome Analysis and Technology Program which was the forerunner of Genome Canada established seven years later

Learn more

1993

With support from the world’s largest independent biotech company, Amgen, Dr. Mak established the Amgen Research Institute in Toronto

Learn more

1996

As part of an effort to translate scientific discoveries into commercial products, Dr. Hayden established NeuroVir Pharmaceutic

Learn more

1997

Dr. Finlay and his team published a seminal paper that showed Salmonella resides inside host cells during infections

Learn more

1997

The Finlay Group showed how enteroaggregative E. coli (EAEC) injects its own receptor into host cells

Learn more

2000

Learning from the success of the South Africa Clinic, Dr. Hayden founded BC’s first Huntington’s Disease Clinic

Learn more

2000

NeuroVir was sold to a German biotechnology company that took NeuroVir’s technology into clinical trials

Learn more

2000

Ron Worton elected President of the American Society for Human Genetics

Learn more

2000

A great mentor, Michael Smith hand-picked Marco Marra to succeed him as Director of the GSC

Learn more

2001

Connie Eaves became the first researcher in Vancouver to commence investigations of human embryonic stem cells (ES) and human induced pluripotent Stem Cells (iPS)

Learn more

2001

Following merger of four Ottawa hospitals to create The Ottawa Hospital, Dr. Worton became the first CEO and Scientific Director of the new Ottawa Hospital Research Institute, and VP Research of the…

Learn more

2002

Dr. Finlay co-founded Inimex Pharmaceuticals Inc., a biopharmaceutical company to facilitate shifting lab work into accessible products

Learn more

2003

At the height of the SARS outbreak Marco Marra and his team of researchers successfully sequenced the SARS coronavirus, providing a basis for both vaccine development and diagnostic testing

Learn more

2004

Along with Dr. Bruce Carleton, Dr. Hayden created Genotype-Specific Approaches to Therapy in Childhood

Learn more

2004

Dr. John Dick identified cancer stem cells in human colon cancer

Learn more

2004

Tak Wah Mak became Director of the Campbell Family for Breast Cancer Research Institute at the Princess Margaret Hospital

Learn more

2005

David MacLennan published his research on the Ca2+ATPase in the Journal of Biological Chemistry in 1970

Learn more

2005

Till and McCulloch published “Perspectives on the Properties of Stem Cells”

Learn more

2006

Onpattro developed to treat transthyretin induced amyloidosis (hATTR), a previously fatal hereditary condition that affects some 50,000 people worldwid

Learn more

2008

The Brain-Body Institute was established at McMaster University

Learn more

2009

Marco Marra and his team became the first to publish a genomic study of breast cancer and its metastasis

Learn more

2012

The Personalized Oncogenomics (POG) project at BC Cancer was established under Marco Marra’s leadership

Learn more

2016

Dr. John Dick provided the first evidence that leukemia stem cell gene expression signatures are clinically relevant

Learn more

2018

Dr. John Dick demonstrated that detection of pre-leukemia haematopoietic stem cells can predict individuals at risk for progression to acute myeloid leukemia up to a decade in advance

Learn more

2018

Nanomedicine-based drug Onpattro approved by the FDA

Learn more